Cyprus Mail reports that Mounjaro is being added to Gesy coverage, both for diabetes and for adults with obesity.
Recap by typeshit. Post by Cyprus Mail on X.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Cardiologist Derek Connolly flags a comparison of pill and injection versions of incretin drugs as worth reading. Tap through for the analysis.
Researchers also saw fewer COPD flare-ups, though they say trials built around breathing outcomes are the next step before drawing firm conclusions.
Loading…